A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes

AIMS: Basal insulin plus oral hypoglycemic agents (OHAs) has not been investigated for early intensive antihyperglycemic treatment in people with newly diagnosed type 2 diabetes. This study is aimed at comparing the short-term (over a period of 12 days) effects of basal insulin glargine plus OHAs an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shuo, Chen, Mu, Chen, Wanling, Lin, Keyi, Mu, Panwei, Zhu, Bilian, Xu, Wen, Wang, Manman, Weng, Jianping, Zeng, Longyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215559/
https://www.ncbi.nlm.nih.gov/pubmed/30420969
http://dx.doi.org/10.1155/2018/2791584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215559/
https://www.ncbi.nlm.nih.gov/pubmed/30420969
http://dx.doi.org/10.1155/2018/2791584

Ejemplares similares